Point72 Asia (Singapore)’s SpringWorks Therapeutics SWTX Stock Holding History

Point72 Asia (Singapore)’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-53,081	Closed	-$2.49M	–	1228
2025 Q2	$2.49M	Buy	+53,081	New	+$2.36M	0.44%	58

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Asia (Singapore)'s SWTX Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 53,081 shares — an estimated $2.49M sold.

Point72 Asia (Singapore) first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $2.49M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Point72 Asia (Singapore) reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Point72 Asia (Singapore) sold 53,081 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.49M.
Point72 Asia (Singapore) first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Point72 Asia (Singapore)'s SpringWorks Therapeutics position peaked at $2.49M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.